$EVGN
Evogene Ltd
PRICE
$0.77 -
Delayed Price
VOLUME
4,685
DAY RANGE
- 0.77
52 WEEK
0.7 - 3.58
Key Metrics
Market Cap
31.71 M
Beta
1.09
Avg. Volume
110.29 K
Shares Outstanding
41.19 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-10
Next Dividend Date
Company Information
Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.
Website: www.evogene.com
HQ: ,
Related News